Gelonghui, May 15 | Xinhua Healthcare (600587.SH) said on an interactive platform that the company is currently focusing on the middle and downstream aspects of the synthetic biology industry chain. The company provides comprehensive support from basic research to industrialization for every application scenario of customers, including high-quality core process equipment, auxiliary process equipment, design, engineering and other products and services. Through a one-stop BPC overall solution. Empower synthetic biology companies to achieve effective commercialization of products and increase efficiency.